Search
Wednesday 22 April 2015
  • :
  • :

Active Trading Stocks Alert - Five Below, Inc. (NASDAQ:FIVE), Red Hat, Inc. (NYSE:RHT), EnLink Midstream Partners, LP (NYSE:ENLK), Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

On Thursday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Five Below, Inc. (NASDAQ:FIVE), Red Hat, Inc. (NYSE:RHT), EnLink Midstream Partners, LP (NYSE:ENLK), Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

Five Below, Inc. (NASDAQ:FIVE), with shares gained 10.34%, closed at $35.55.

Red Hat, Inc. (NYSE:RHT), with shares jumped 10.09%, settled at $75.36, hitting new 52-week high of $76.70.

EnLink Midstream Partners, LP (NYSE:ENLK), with shares climbed 3.06%, and closed at $25.25.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), surged 8.46%, and closed at $282.69.

Latest NEWS regarding these Stocks are depicted underneath:

Five Below, Inc. (NASDAQ:FIVE)

Formerly on March 17, Five Below, Inc. (FIVE), declared its initial entry into Kentucky with the opening of its first stores in Louisville on Friday, March 20th.

“Entering Louisville is an important next step as we continue to grow our footprint across the country,” said Joel Anderson, CEO of Five Below. “We’re excited to serve new customers in this dynamic city. Kids and parents looking for a fun place to shop for trend-right, high quality products at a great value will surely enjoy Five Below.”

The Philadelphia-based corporation is one of the fastest growing retailers in the country with more than 370 stores in 22 states. It anticipates to cut the ribbon on about 70 new stores this year, on top of opening 62 stores in 2014. Catering to teens, pre-teens and their parents, Five Below carries an ever-evolving and exciting assortment of cell phone cases and chargers, remote control cars, yoga pants, graphic tees, nail polish, baseball and soccer balls, tons of candy and seasonal must-haves for Easter, Summer, Back-to-School, Christmas and more. Everything, everyday, is just $5 and below. Its stores are a vibrant, colorful and high-energy destination.

Five Below, Inc. operates as a specialty value retailer in the United States. It offers various products priced at $5 and below. The corporation offers accessories, such as novelty socks, sunglasses, jewelry, scarves, gloves, hair accessories, and ‘attitude’ T-shirts, in addition to beauty products, counting nail polish, lip gloss, fragrance, and branded cosmetics; and items used to complete and personalize living space comprising glitter lamps, posters, frames, fleece blankets, pillows, candles, incense and related items, and storage options for the customer’s room and locker.

Red Hat, Inc. (NYSE:RHT)

Red Hat, Inc. (RHT), declared that its Board of Directors has authorized the repurchase of up to $500 million of the Corporation’s ordinary stock from time to time on the open market or in privately negotiated transactions.

The new program replaces the previous $300 million repurchase program that is planned to expire on March 31, 2015. About $220 million was used under the previous plan through March 25, 2015.

The timing and the amount of any repurchases of ordinary stock will be determined by Red Hat administration based on its evaluation of market conditions and other factors. Repurchases of ordinary stock may also be made under a Rule 10b5-1 plan, which would permit ordinary stock to be repurchased when the Corporation might otherwise be precluded from doing so under insider trading laws. The repurchase program may be suspended or suspended at any time. Any repurchased ordinary stock will be accessible for use in connection with the Corporation’s stock plans and for other corporate purposes.

The repurchase program will be funded using the Corporation’s operating cash flow. As of February 28, 2015, the Corporation had cash and investments of about $1.81 billion.

Red Hat had about 183.5 million shares of ordinary stock outstanding as of February 28, 2015.

Red Hat, Inc. provides open source software solutions to enterprise customers worldwide. It develops and offers operating system, virtualization, middleware, storage, and cloud technologies.

EnLink Midstream Partners, LP (NYSE:ENLK)

EnLink Midstream Partners, LP (ENLK), and EnLink Midstream, LLC (ENLC), declared that Andrew A. Deck has been designated Senior Vice President of the Permian Basin. Mr. Deck will partner with the Gas and Liquids Business Unit leadership teams to identify and execute commercial projects that support EnLink’s growth strategy in West Texas.

Mr. Deck served as the Chief Executive Officer of Coronado Midstream LLC until its recent sale to EnLink. He received a Bachelor of Science in Chemical Engineering from Oklahoma State University.

Enlink Midstream Partners, LP, through its partner, EnLink Midstream Operating, LP, provides midstream energy services. The corporation provides gathering, transmission, processing, fractionation, brine, and marketing services to producers of natural gas, natural gas liquids (NGL), crude oil, and condensate.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

Formerly on March 20, Intercept Pharmaceuticals, Inc. (ICPT), declared new subgroup analyses from the Phase 2b FLINT trial of obeticholic acid (OCA) in patients with nonalcoholic steatohepatitis (NASH). Intercept is presenting the data in two posters during today’s poster session at the American Association for the Study of Liver Disease (AASLD) and Industry Colloquium: Novel Targets and Therapies in Liver Disease.

Obeticholic acid (OCA) is a first-in-class farnesoid X receptor (FXR) agonist being developed for primary biliary cirrhosis (PBC), NASH and other chronic liver indications. Intercept has initiated a rolling New Drug Application with the FDA for PBC, and anticipates to complete the NDA and MAA submission in 2Q 2015. The commercial launch of OCA in the U.S. and Europe is planned in 2016. OCA was also recently granted breakthrough therapy designation by FDA for the treatment of NASH with liver fibrosis.

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical corporation, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *